Skip to main content

Table 4 Diagnostic performance of WB-MRI

From: Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response

 

Imaging response

 

RECIST 1.1

MDA criteria

MDA-DWI criteria

Clinical CR

Sen: 4.5%, Spec: 98.1%, PPV: 50.0%, NPV: 71.2%

Sen: 4.5%, Spec: 98.1%, PPV: 50.0%, NPV: 71.2%

Sen: 4.5%, Spec: 98.1%, PPV: 50.0%, NPV: 71.2%

Clinical OR

Sen: 54.4%, Spec: 100%, PPV: 100%, NPV: 40.9%

Sen: 61.4%, Spec: 94.4%, PPV: 97.2%, NPV: 43.6%

Sen: 84.2%, Spec: 94.4%, PPV: 98.0%, NPV: 65.4%

Clinical PD

Sen: 88.9%, Spec: 94.7%, PPV: 84.2%, NPV: 96.4%

Sen: 88.9%, Spec: 94.7%, PPV: 84.2%, NPV: 96.4%

Sen: 88.9%, Spec: 94.7%, PPV: 84.2%, NPV: 96.4%

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us